156 filings
Page 4 of 8
8-K
if1rgre 20ozjnl82
10 Jan 20
Entry into a Material Definitive Agreement
4:16pm
8-K
dz64zba
6 Jan 20
Departure of Directors or Certain Officers
7:00am
8-K
a48i7dvy0ltrvkggjj3
19 Dec 19
Other Events
7:00am
8-K
fifaz
16 Dec 19
Akcea Therapeutics Announces New Appointments to its Board of Directors
4:15pm
8-K
86yw9 v5nv5q5aq4mfm8
4 Dec 19
Akcea Announces Appointment of New Chief Operating Officer
7:30am
8-K
kos40fe
5 Nov 19
Akcea Reports Financial Results and Highlights for Third Quarter 2019
12:00am
8-K
ci1txv t1ixz3yzub7yq
23 Oct 19
Akcea Announces Appointment of New Chief Commercial Officer
7:30am
8-K
zi20p
17 Oct 19
Entry into a Material Definitive Agreement
4:16pm
8-K
1mmu oxj2xsen09p9
8 Oct 19
Akcea and Pfizer Inc. Announce Licensing Agreement for Akcea and Ionis to earn $250 million license fee
4:16pm
8-K
1ndbg23w jy7jl
23 Sep 19
Akcea Announces CEO Transition and Elects Two New Board Members
7:15am
8-K
cdyqz uig
6 Aug 19
Akcea Reports Financial Results and Highlights for Second Quarter 2019
4:16pm
CT ORDER
ewu9p85330 r0he
5 Jun 19
Confidential treatment order
11:30am
S-8
h4s82
20 May 19
Registration of securities for employees
4:23pm
8-K
4hbyw mu6
8 May 19
Akcea Reports Financial Results and Highlights for First Quarter 2019
4:16pm
DEFA14C
03ppo5omp2kfrbo xgx
29 Apr 19
Additional information
8:43am
DEF 14C
lgikrsaz
29 Apr 19
Information statement
8:41am
8-K
gvl gu68mfslkcf8
26 Apr 19
Submission of Matters to a Vote of Security Holders
4:29pm